arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Encompass Health Corporation

EHC Health Care Hospital/Nursing Management
$121.79
▲ +0.0% Today
as of Sep 4, 16:48 ET
Last 30 days +4.96% Jul 28 → Sep 04
$109.28 $113.72 $118.15 $122.59 $127.03 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$121.53
High
$122.62
Low
$121.64
Volume
$507,474
Avg Vol
$972,992
Mkt Cap
$12.2B
P/E (TTM)
25.86
Beta
—
52w High
$127.99
52w Low
$92.77
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 15:30 Zacks
Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
Sep 1 · 16:31 MT Newswires
Encompass Health Insider Sold Shares Worth $630,166, According to a Recent SEC Filing
Aug 25 · 14:20 Zacks
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$93
$128
82% of range
Avg surprise (last 2)
+15.9%
Avg reaction (last 1)
+0.7%
100% positive
Latest IV / EM
25%
EM ±3.9% · $120 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.84$1.11$1.38$1.66$1.93 Actual $0.87Actual $0.90Actual $0.84Actual $1.10Actual $1.12Actual $1.06Actual $1.37Est $1.19Actual $1.40Est $1.20Actual $1.24Actual $1.93Actual $1.54 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$419M$839M$1.3B$1.7B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.54 — — — — financials
Tue Mar 31, 2026Mar 2026 $1.93 — — — — financials
Tue Sep 30, 2025Sep 2025 $1.24 — — — — financials
Mon Aug 4, 2025Jun/2025 $1.40 $1.20 +16.7% — — earnings
Thu Apr 24, 2025Mar/2025 $1.37 $1.19 +15.1% — +0.7% earnings
Mon Sep 30, 2024Sep 2024 $1.06 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.12 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.10 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.84 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.90 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.87 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.60B$1.59B—$1.48B$1.46B$1.46B—$1.35B
Cost of revenue————————
Gross profit————————
Operating income————————
Net income$154M$194M—$126M$142M$152M—$108M
EPS (diluted)$1.54$1.93—$1.24$1.39$1.48—$1.06

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$108M$110M$72M$49M$99M$96M$85M$148M
Inventory————————
Total current assets$1.04B$1.03B$906M$870M$918M$911M$887M$934M
Total assets$7.46B$7.31B$7.09B$6.87B$6.79B$6.64B$6.53B$6.46B
Long-term debt————————
Total liabilities$4.00B$3.95B$3.81B$3.68B$3.70B$3.70B$3.69B$3.73B
Total equity$2.60B$3.31B$2.44B$2.37B$3.03B$2.88B$2.07B$2.67B

Implied volatility — last 90 days

23%49%76%102%128% Jun 07 — IV 36% · EM ±4.9%Jun 08 — IV 37% · EM ±4.9%Jun 09 — IV 34% · EM ±4.3%Jun 10 — IV 35% · EM ±4.1%Jun 11 — IV 43% · EM ±4.8%Jun 12 — IV 38% · EM ±3.9%Jun 15 — IV 47% · EM ±3.4%Jun 16 — IV 45% · EM ±2.7%Jun 17 — IV 128% · EM ±5.4%Jun 19 — IV 32% · EM ±7.1%Jun 22 — IV 34% · EM ±7.0%Jun 23 — IV 30% · EM ±6.1%Jun 24 — IV 33% · EM ±6.6%Jun 25 — IV 33% · EM ±6.4%Jun 26 — IV 30% · EM ±5.8%Jun 29 — IV 32% · EM ±5.7%Jun 30 — IV 31% · EM ±5.4%Jul 01 — IV 35% · EM ±5.9%Jul 02 — IV 33% · EM ±5.4%Jul 03 — IV 34% · EM ±5.4%Jul 06 — IV 37% · EM ±5.1%Jul 07 — IV 34% · EM ±4.4%Jul 08 — IV 31% · EM ±3.9%Jul 09 — IV 34% · EM ±4.1%Jul 10 — IV 31% · EM ±3.4%Jul 13 — IV 36% · EM ±3.0%Jul 14 — IV 42% · EM ±3.0%Jul 15 — IV 57% · EM ±3.4%Jul 16 — IV 128% · EM ±5.3%Jul 20 — IV 36% · EM ±8.5%Jul 21 — IV 36% · EM ±8.3%Jul 22 — IV 36% · EM ±8.2%Jul 23 — IV 40% · EM ±9.0%Jul 24 — IV 40% · EM ±8.8%Jul 27 — IV 45% · EM ±9.3%Jul 28 — IV 46% · EM ±9.4%Jul 29 — IV 47% · EM ±9.4%Jul 30 — IV 46% · EM ±8.9%Jul 31 — IV 47% · EM ±9.0%Aug 03 — IV 50% · EM ±8.9%Aug 04 — IV 49% · EM ±8.5%Aug 05 — IV 57% · EM ±9.5%Aug 06 — IV 35% · EM ±5.6%Aug 07 — IV 32% · EM ±5.1%Aug 10 — IV 30% · EM ±4.2%Aug 11 — IV 32% · EM ±4.3%Aug 12 — IV 30% · EM ±3.7%Aug 13 — IV 32% · EM ±3.8%Aug 14 — IV 26% · EM ±2.9%Aug 17 — IV 60% · EM ±5.0%Aug 18 — IV 74% · EM ±5.3%Aug 19 — IV 66% · EM ±3.9%Aug 20 — IV 93% · EM ±3.9%Aug 24 — IV 25% · EM ±5.3%Aug 25 — IV 26% · EM ±5.2%Aug 26 — IV 27% · EM ±5.3%Aug 27 — IV 25% · EM ±4.9%Aug 28 — IV 25% · EM ±4.8%Aug 31 — IV 27% · EM ±4.7%Sep 01 — IV 24% · EM ±4.1%Sep 02 — IV 25% · EM ±4.1%Sep 03 — IV 24% · EM ±3.9%Sep 04 — IV 25% · EM ±3.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in